| Safe Launches Safenet Beta, Giving SAFE Token Holders a Role in Network Security |
Globe Newswire |
04/02 |
07:34 |
| Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer |
Globe Newswire |
04/02 |
07:30 |
| Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections |
Globe Newswire |
04/02 |
07:30 |
| [Latest] Global Environmental Mass Spectrometry Market Size/Share Worth USD 6.47 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) |
Globe Newswire |
04/02 |
07:30 |
| Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives |
Globe Newswire |
04/02 |
07:30 |
| Namib Minerals Provides Business Update and Reports Full Year 2025 Results |
Globe Newswire |
04/02 |
07:25 |
| It has been 50 years since the last perfect NCAA champion. Indiana will be honored not far from home |
AP Online |
04/02 |
07:10 |
| Cylinder Health launches Stool Scan to innovate and standardize one of GI care’s most subjective signals |
Globe Newswire |
04/02 |
07:10 |
| Microchip Technology Earns IEC 62443-4-1 ML2 Industrial Automation and Control System Certification |
Globe Newswire |
04/02 |
07:06 |
| Cartesian Therapeutics Announces New Employment Inducement Grants |
Globe Newswire |
04/02 |
07:05 |
| Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC) |
Globe Newswire |
04/02 |
07:01 |
| Lightbridge to Participate at Upcoming Investor Conferences |
Globe Newswire |
04/02 |
07:00 |
| OTC Markets Group Welcomes Vallant Financial Inc. to OTCQX |
Globe Newswire |
04/02 |
07:00 |
| Hudbay Announces Repayment of 2026 Senior Unsecured Notes |
Globe Newswire |
04/02 |
07:00 |
| Perspective Therapeutics to Participate in Upcoming Investor Conferences |
Globe Newswire |
04/02 |
07:00 |
| Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response |
Globe Newswire |
04/02 |
07:00 |
| Sitryx nominates novel, oral GLS1 inhibitor for clinical development in moderate to severe asthma |
Globe Newswire |
04/02 |
07:00 |
| L3Harris Selects Mercury To Provide Solid-State Data Recorders for SDA’s Tranche 3 Tracking Layer Satellites |
Globe Newswire |
04/02 |
07:00 |
| Neutrolis Announces Positive First-in-Human Phase 1a Results from LIBERATE-I Trial of NTR-1011, a First-in-Class DNASE1L3 Fusion Protein |
Globe Newswire |
04/02 |
07:00 |
| Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development |
Globe Newswire |
04/02 |
07:00 |
| Wix Announces Preliminary Results of Modified Dutch Auction Tender Offer |
Globe Newswire |
04/02 |
07:00 |
| GXO Expands with Pandora in North America |
Globe Newswire |
04/02 |
07:00 |
| Liberty Gold Completes Sale of the Gage Project |
Globe Newswire |
04/02 |
07:00 |
| Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update |
Globe Newswire |
04/02 |
06:50 |
| Scorpio Tankers Inc. Announces Strategic Collaboration with AMPERA, Inc. to Develop & Commercialize Micronuclear Solutions for Global Marine and Shipping Markets |
Globe Newswire |
04/02 |
06:44 |
